Previous 10 | Next 10 |
home / stock / tevjf / tevjf news
Horizon Therapeutics has morphed into a biotech star due to its new compound Tepezza. Tepezza is approved for the treatment of thyroid eye disease otherwise known as TED. Tepezza is a star generating faster growth as widespread adoption has occurred at a pace faster than expected....
Teva's revenues disappointed, but this was likely due to COVID-dependent market volatility. In contrast, margins were up significantly, which should benefit long-term shareholders over time. The key issue holding back the stock right now is the opioid litigation, which is unlikely...
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2020 Q3 earnings call. For further details see: Teva Pharmaceutical Industries Limited 2020 Q3 - Results - Earnings Call Presentation
Teva Pharmaceutical Industries Ltd (TEVA) Q3 2020 Earnings Conference Call November 05, 2020, 08:00 ET Company Participants Kevin Mannix - SVP, IR Kare Schultz - President, CEO & Director Eli Kalif - EVP & CFO Brendan O'Grady - EVP, North America Commercial Conference Call Participant...
These are my quick thoughts on this newly launched and interesting ETF. The fund is the first fund to target a weekly dividend payout. This fund is probably too new to invest in, but it will certainly be interesting to watch. For further details see: TGIF: Newly Launched...
NLS Pharmaceutics has filed to raise $20 million in a U.S. IPO. The firm is advancing treatments for narcolepsy and ADHD. NLSP is thinly capitalized and has made no apparent progress on beginning trials for its lead candidate, so I'll pass on the IPO. For further details see...
Quick Take American Well Corporation ( AMWL ) has filed to raise $525 million in an IPO of its Class A common stock, according to an S-1 registration statement . Amwell provides a telehealth services delivery platform for healthcare service providers in the United States. AMWL is growin...
Yet another lawsuit One week ago, Teva ( TEVA ) suffered yet another few high-volatility days as the circulating rumors were confirmed: Teva will be charged in a criminal antitrust investigation by the DOJ for overcharging consumers by "at least $350 million." Reuters mentions that...
Teva receives tentative FDA nod for generic idiopathic pulmonary fibrosis treatment Teva Pharmaceutical Industries ( TEVA ) received tentative approval from the FDA for generic pirfenidone. The drug candidate is aimed towards treating idiopathic pulmonary fibrosis. The tentative approval i...
A stricter interpretation of anti-kickback rules Yet another kickback scheme allegation hit Teva ( TEVA ) yesterday, sending its stock down over 10%. - New about this umpteenth lawsuit, however, was that it related to Copaxone, i.e. Teva's own drug, so this time Teva could not point to ...
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Ltd Company Name:
TEVJF Stock Symbol:
OTCMKTS Market:
Teva Pharmaceutical Industries Ltd Website: